Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard Newcomb Stillwell currently holds 22,700 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Newcomb Stillwell has been a net neutral trader of TNXP stock. They have purchased $0 and sold $0 worth of shares.
Richard Newcomb Stillwell's most recent insider trade was on May 12, 2026, when they sold 22,700 shares at $0.00 per share.
Richard Newcomb Stillwell serves as Executive at Tonix Pharmaceuticals Holding Corp. (TNXP). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Richard Newcomb Stillwell holds the position of Executive at Tonix Pharmaceuticals Holding Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Richard Newcomb Stillwell has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Richard Newcomb Stillwell was on May 12, 2026, when they purchased $0 worth of TNXP shares. This transaction involved 22,700 shares at N/A per share.
Richard Newcomb Stillwell currently owns 22,700 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard Newcomb Stillwell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard Newcomb Stillwell has 2 Form 4 filings on record as an insider at Tonix Pharmaceuticals Holding Corp..
Set alerts for Richard Newcomb Stillwell and 40,000+ other insiders.